Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Subject With Idiopathic Overactive Bladder

Medy-Tox216 enrolled

Overview

This study is for patients who have idiopathic overactive bladder symptoms. This study will evaluate efficacy and safety of Neuronox® against placebo.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

216

Conditions

Overactive Bladder

Interventions

NeuronoxDRUG

intradetrusor injection

PlaceboDRUG

intradetrusor injection

Eligibility

Sex: ALLMin age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male and female subjects aged above 20 * Patient with overactive bladder symptoms lasting at least 6 months Exclusion Criteria: * Patient with a history of surgery or a disease that may affect bladder function.

Locations (1)

Konkuk University Hospital

Seoul, South Korea

Outcomes

Primary Outcomes

The change in the daily average UI (Urinary Incontinence) episodes

Time frame: 12 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.